"Jobs was being Jobs: He was telling the truth, he was simplifying the truth, he was exaggerating the truth, he was leaving part of the truth out." (Image by acaben.)

Tom Junod’s 2008 profile about Steve Jobs in Esquire becomes an even better read now for very unfortunate reasons. (Thanks Longform.) The article’s opening:

“One day, Steve Jobs is going to die.

First, he is mortal. Second, the odds against him are not only actuarial — the inevitable odds we all face — they are clinical. Four years ago, he announced in a memo to his employees that he had undergone surgery, that the surgery was for the removal of a malignant tumor, that the tumor was on his pancreas, and that the surgery was, as he put it, successful. An exceptional man who specializes in exceptionalizing himself — he has been an economic force for thirty years, and it’s still hard to put him in a category, or even to say exactly what he does — he responded to his disease by exceptionalizing it as well. He was at pains to say that the pancreatic cancer he had was not that kind of pancreatic cancer — not the kind that kills you, without much room for exception, in six months or so — but rather ‘a very rare form of pancreatic cancer… which represents about 1 percent of the total cases…each year, and can be cured by surgical removal.’ Even in extremis, Jobs was being Jobs: He was telling the truth, he was simplifying the truth, he was exaggerating the truth, he was leaving part of the truth out. It is true that his cancer, originating not in the ductwork of the pancreas but rather in the islets of Langerhans, is slow growing and, in the words of one expert, can be addressed ‘with curative intent’; it is also true that even after surgery, the average patient lives about five years.”